Therapy and Psychotropic Medication Use in Young Children With Autism Spectrum Disorder
- 1 April 2020
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 145 (Supplement), S99-S107
- https://doi.org/10.1542/peds.2019-1895M
Abstract
BACKGROUND AND OBJECTIVES: Guidelines suggest young children with autism spectrum disorder (ASD) receive intensive nonpharmacologic interventions. Additionally, associated symptoms may be treated with psychotropic medications. Actual intervention use by young children has not been well characterized. Our aim in this study was to describe interventions received by young children (3-6 years old) with ASD. The association with sociodemographic factors was also explored. METHODS: Data were analyzed from the Autism Speaks Autism Treatment Network (AS-ATN), a research registry of children with ASD from 17 sites in the United States and Canada. AS-ATN participants receive a diagnostic evaluation and treatment recommendations. Parents report intervention use at follow-up visits. At follow-up, 805 participants had data available about therapies received, and 613 had data available about medications received. RESULTS: The median total hours per week of therapy was 5.5 hours (interquartile range 2.0-15.0), and only 33.4% of participants were reported to be getting behaviorally based therapies. A univariate analysis and a multiple regression model predicting total therapy time showed that a diagnosis of ASD before enrollment in the AS-ATN was a significant predictor. Additionally, 16.3% of participants were on >= 1 psychotropic medication. A univariate analysis and a multiple logistic model predicting psychotropic medication use showed site region as a significant predictor. CONCLUSIONS: Relatively few young children with ASD are receiving behavioral therapies or total therapy hours at the recommended intensity. There is regional variability in psychotropic medication use. Further research is needed to improve access to evidence-based treatments for young children with ASD.This publication has 28 references indexed in Scilit:
- Child and Family Characteristics Influencing Intervention Choices in Autism Spectrum DisordersFocus on Autism and Other Developmental Disabilities, 2012
- Nonmedical Interventions for Children With ASD: Recommended Guidelines and Further Research NeedsPEDIATRICS, 2012
- Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum DisordersPEDIATRICS, 2012
- Child and family factors associated with the use of services for preschoolers with autism spectrum disorderResearch in Autism Spectrum Disorders, 2012
- A Systematic Review of Early Intensive Intervention for Autism Spectrum DisordersPEDIATRICS, 2011
- Applied behavior analytic intervention for autism in early childhood: Meta-analysis, meta-regression and dose–response meta-analysis of multiple outcomesClinical Psychology Review, 2010
- Disparities in Diagnosis and Access to Health Services for Children with Autism: Data from the National Survey of Children's HealthJournal of Developmental & Behavioral Pediatrics, 2008
- Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum DisordersPEDIATRICS, 2008
- Management of Children With Autism Spectrum DisordersPEDIATRICS, 2007
- Internet survey of treatments used by parents of children with autismResearch in Developmental Disabilities, 2006